Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy

Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.